THE IMPACT OF INVESTMENT IN RESEARCH AND DEVELOPMENT ACTIVITIES ON THE PROFITABILITY OF PHARMACEUTICAL COMPANIES

A COST ACCOUNTING APPROACH

Authors

DOI:

https://doi.org/10.26458/2315

Abstract

Investing in research and development (R&D) activities greatly impacts the assessment of the company’s finances and performance, which is why the issue of the accounting treatment of these costs is so important. The aim of this paper is to examine the relationship between investment in R&D activities and the profitability of pharmaceutical companies, i.e., to see whether R&D activities can affect the financial position and performance of 30 pharmaceutical companies in the period from 2010 to 2020. The obtained results show that investing in R&D activities has a positive effect on net income, earnings before interest and taxes, and earnings per share (EPS).

Author Biographies

Dr Bojana Novićević Čečević, University of Niš, Faculty of Economics

Associate Professor

Jovana Milenović, University of Niš, Faculty of Economics

Junior Teaching Assistant

Dr Tamara Rađenović, University of Niš, Faculty of Occupational Safety

Assistant Professor

Downloads

Published

2023-09-07

How to Cite

Novićević Čečević, B., Milenović, J., & Rađenović, T. (2023). THE IMPACT OF INVESTMENT IN RESEARCH AND DEVELOPMENT ACTIVITIES ON THE PROFITABILITY OF PHARMACEUTICAL COMPANIES: A COST ACCOUNTING APPROACH. Annals of Spiru Haret University. Economic Series, 23(1). https://doi.org/10.26458/2315

Issue

Vol. 23 No. 1 (2023)

Section

ACADEMIA PAPERS

License

Copyright (c) 2023 Dr Bojana Novićević Čečević, Jovana Milenović, Dr Tamara Rađenović

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.